Hosted by the American College of Toxicology and the Society of Toxicologic Pathology in Collaboration with the British Toxicology Society and the Teratology Society
Speaker: Sherry J. Morgan, DVM, PhD, DACVP, DABVT, DABT, Senior Research Fellow, AbbVie
Abstract for Animal Models of Disease for Nonclinical Safety Assessment: Pharmaceutical Industry Survey:
Considerations for the use of animal models of disease will be discussed with specific examples of organ systems and/or responses that are generally either well or poorly predicted with the use of conventional animal models. The results of a recent survey (IQ Focus Group) that queried the current practices as it pertains to the use of animal models in nonclinical safety assessment will be presented. Attention will begiven to differentiating the use of animal models of disease in discovery vs. development as well as describing common themes across industry.
This presentation was sponsored by AbbVie. AbbVie contributed to the design, research, and interpretation of data, writing, reviewing, and approving the publication. Sherry Morgan is an employee of AbbVie.
View Webinar Recording
Webinar materials are property of the speaker and the American College of Toxicology and are intended for use by the host society and cohost societies' members for educational purposes only. Any distribution or copy of the materials is prohibited. By downloading from the link provided you agree to the terms expressed above.